New Oxfam research shows that four pharmaceutical corporations – Abbott, Johnson & Johnson, Merck & Co (MSD), and Pfizer – systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year – money that is urgently needed to meet the health needs of people in these countries.
This report examines the failings of the global tax system that facilitate mass tax avoidance. It looks at one example of a multinational company (MNC) that Oxfam thinks is not paying its fair share. Moreover, it calls on governments and business to implement the reforms that are needed to stop MNCs from avoiding paying their fair share of tax in the future.